Back
American Software 10K Form
Buy
51
AMSWA
American Software
Last Price:
10.52
Seasonality Move:
-2.1%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-03-01 | 10Q | AMSWA/American Software Quarterly |
2023-12-11 | 10Q | AMSWA/American Software Quarterly |
2023-09-01 | 10Q | AMSWA/American Software Quarterly |
2023-03-03 | 10Q | AMSWA/American Software Quarterly |
2022-12-02 | 10Q | AMSWA/American Software Quarterly |
2022-09-02 | 10Q | AMSWA/American Software Quarterly |
Receive AMSWA News And Ratings
See the #1 stock for the next 7 days that we like better than AMSWA
AMSWA Financial Statistics
Sales & Book Value
Annual Sales: | $102.52M |
---|---|
Cash Flow: | $7.31M |
Price / Cash Flow: | 21.86 |
Annual Sales: | $3.93 |
Price / Book: | 2.69 |
Profitability
EPS (TTM): | 0.34000 |
---|---|
Net Income (TTM): | $11.37M |
Gross Margin: | $66.42M |
Return on Equity: | 8.44% |
Return on Assets: | 6.05% |
American Software Earnings Forecast
Key American Software Financial Ratios
- The Gross Profit Margin over the past 41 years for AMSWA is 64.79%.
- The Selling, General & Administrative Expenses for AMSWA have been equal to 43.03% of Gross Profit Margin.
- The Research & Development expenses have been 17.22% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- The Net Earning history of AMSWA is 11.09% of Total Revenues.
- Per Share Earnings over the last 41 years have been positive in 21 years.
American Software Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Software |
Sector: | Information Technology |
Current Symbol: | AMSWA |
CUSIP: | 029683 |
Website: | amsoftware.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 1.97 |
Quick Ratio: | 1.86 |
Price-to-Earnings
Trailing P/E Ratio: | 30.97 |
---|---|
Forward P/E Ratio: | 26.11 |
AMSWA Technical Analysis vs Fundamental Analysis
Buy
51
American Software (AMSWA)
is a Buy
Is American Software a Buy or a Sell?
-
American Software stock is rated a Buy
The current American Software [AMSWA] share price is $10.53. The Score for AMSWA is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.